Preprint examines CD4+ T-cells in high-grade glioma response
A new study uses a hypermutated glioma model to investigate determinants of tumor-infiltrating T-cells driving responses to immune checkpoint inhibitors.
A new study uses a hypermutated glioma model to investigate determinants of tumor-infiltrating T-cells driving responses to immune checkpoint inhibitors.